Skip to Content

Venetoclax (Venclexta) for the Treatment of Acute Myeloid Leukemia

Download PQI pdf 0.2MB

Last Updated: July 18, 2025

By: Alison Carulli, PharmD, BCOP

About this PQI

The purpose of this document is to discuss the approval of venetoclax for acute myeloid leukemia (AML) and the management of select side effects.

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care.

Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Find a PQI